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Abstract: A randomized controlled trail was conducted to examine the effectiveness of a depression
and anxiety prevention program ‘Een Sprong Vooruit’ (A Leap Forward) among adolescent girls
with a high familial risk (N = 142). The results showed neither effects of the prevention program
directly after the intervention, nor at 6 or 12 months follow-up on depression and anxiety symptoms.
Further, latent growth curve modeling (LGCM) was used to examine whether the growth functions
for the intervention and the control condition were different. The slope representing the change
in depression symptoms was not significantly different between the intervention and the control
condition. For anxiety symptoms, the difference between slopes was also not significant. Based on
these results, we suggested that these high-risk adolescent girls might benefit more from a more
intensive prevention program.
Keywords: depression; anxiety; adolescents; prevention; parental psychopathology; randomized
controlled trial
1. Introduction
Depression and anxiety are common mental health disorders and are among the most costly health
problems [1–3]. During adolescence, the rates of depression and anxiety rise dramatically [4]. Among
13 to 17-year old females, the lifetime prevalence of depression is estimated on 16.8% [5]. For anxiety
disorders, lifetime prevalence in the same age group is estimated on 38.3% [5]. These numbers only
account for clinical diagnoses of these disorders, and adolescents with elevated symptoms below the
clinical thresholds are not considered.
Children of parents with a depressive disorder are three times more likely to develop depression
symptoms compared to children of parents without mental health problems [6,7]. For children
of parents with an anxiety disorder, it is up to seven times more likely that they develop anxiety
symptoms [7,8]. Besides the parental psychopathology itself, dysfunctional parenting behavior is
found to be associated with an increased risk for depressive and anxiety disorders in offspring [9,10].
Especially negative and affectionless behavior in parents is related to emotional problems in
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children [11]. Because of the risk of parental psychopathology on emotional problems, it is important
to aim prevention programs on youth with parents with mental health problems.
The presence of depression or anxiety disorders at a young age is strongly associated with
psychopathology later in life [12–15]. Suffering from emotional problems during adolescence, but also
having elevated symptoms, is negatively related to social and family functioning [16,17], associated
with poor academic performance [15,17,18], related to depression and anxiety in later life [4,19], and can
even lead to suicide [20,21].
Because of detrimental consequences of developing depression and anxiety during adolescence,
reducing the risk and decreasing potential elevated symptoms of depression and anxiety is pivotal.
Adolescence seems, therefore, an important life phase to implement depression and anxiety prevention
programs. Recent review studies found that there is less evidence for the effectiveness of universally
delivered depression prevention in adolescence [22,23]. Further, the effects of universally delivered
anxiety prevention are notoriously low, and in particular lower than the effects of selective and
indicated prevention [23–25]. Prevention programs that are selective or indicated, and thus focus
on adolescents at risk for developing depression or anxiety, have shown to reduce depression or
anxiety symptoms or reduce the incidence of depression or anxiety disorders. The reason might be that
high-risk individuals, participating in selective or indicated prevention programs, are more effectively
engaged in the prevention program because they are motivated by their distress, which is not the case
in non-risk individuals [26].
Depression and anxiety disorders in adolescents are known to have a large comorbidity, shown
in high diagnostic comorbidity rates [27,28] as well as in highly correlated symptoms [29], and the
co-occurrence of depression and anxiety symptoms is related to greater severity in symptoms [30].
Further, research has shown that depression and anxiety are characterized by similar negative
cognitions, negative affect, and elevated distress [31,32]. By focusing on transdiagnostic underlying
mechanisms of both depression and anxiety, and therefore providing intervention strategies for
symptoms of both disorders, there is potentially a larger benefit of prevention programs [31,33].
Cognitive behavioral therapy has shown to be a highly efficacious treatment of depression and
anxiety [34]. The techniques used in cognitive behavioral therapy are known to target the underlying
mechanisms of both depression and anxiety, such as to improve negative affect, decrease distress,
and increase of cognitive coping by experiencing more positive cognitions [35]. Prevention programs
departing from cognitive behavioral therapy might therefore be appropriate for adolescents to
decrease elevated depression and anxiety symptoms and to prevent the onset of both depression
and anxiety disorders.
The present study evaluated the effects of a prevention program aimed at the prevention of
depression as primary outcome and anxiety as secondary outcome for adolescent girls with a high
familial risk in a randomized controlled trial. Females are known to have a heightened risk on
developing depression or anxiety symptoms [5]. Differences between males and females arise
during adolescence and females show more often depression and anxiety symptoms [5] and are
more vulnerable to develop depression and anxiety disorders [36]. To examine whether the program
was effective, we tested effects directly after the preventive intervention and long-term effects after six
and twelve months for depression symptoms and anxiety symptoms separately. The main hypothesis
was that participants in the intervention condition would show a lower level of depression and anxiety
symptoms compared to participants in the control condition.
2. Method
2.1. Ethics
The study was approved by the medical ethics committee CMO Region Arnhem-Nijmegen,
The Netherlands (NL41344.091.12). All participants provided written informed consent. The trial
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was registered in the Dutch Trial Register (NTR) as NTR3720. Results of this study were reported in
accordance with the CONSORT 2010 statement for reporting parallel group randomized trials [37].
2.2. Procedure
A preventive intervention aimed at preventing depression and anxiety in adolescent girls
with high familial risk was examined with a non-blinded randomized controlled trial with two
conditions (intervention versus control) [38]. A total of 862 female adolescents in the first and
second year of five secondary schools located in rural regions in the middle and south of the
Netherlands, from vocational level up to pre-university level, gave passive consent and were screened
on depression symptoms using the Children’s Depression Inventory 2 (CDI-2) [39], anxiety symptoms
using the Spence Children’s Anxiety Scale (SCAS) [40], suicidal ideation using one item from the
CDI-2, and perceived parental psychopathology according to the adolescents using a self-developed
instrument. One-hundred-and-seven female adolescents declined screening. Inclusion criteria were
being aged between 11–15 years old, having increased levels of depression (CDI-2 ≥ 15) and/or
anxiety (SCAS ≥ 39), having at least one of the parents with parental psychopathology based on
adolescents’ perception, and having sufficient knowledge of the Dutch language. Exclusion criteria
were the absence of parental permission, adolescent already receiving treatment for mental health
problems, and presence of prominent suicidal ideation (score 2 on CDI-2 item: a desire to kill oneself,
if given the chance).
Of these 862 girls, 163 met the eligibility criteria of which three could not be reached, one received
no parental permission, six already received care, and eleven declined participation. In total, 142 girls
gave written informed consent together with their parents; 69 participated in the intervention condition
and 73 in the control condition. Participants in the intervention condition were assessed at baseline (T0),
after two sessions (T1), after four sessions (T2), post-intervention (T3), at 6 months (T4) and 12 months
(T5) follow-up. Participants in the control condition were assessed at the same time points. In addition,
they were offered to follow the preventive intervention as soon as the study ended. Participants in
both conditions received rewards when they completed all assessments.
2.3. Sample Size
A power calculation indicated that to detect a medium effect size (Cohen’s d = 0.50) on depression
symptoms at 12 months follow-up using a two-tailed test with α = 0.05 and power (1−β) = 0.80,
64 participants were needed per condition. We accounted for potential attrition and missing data,
and therefore, we increased the sample size by 25%, resulting in 160 participants (80 in the intervention
condition and 80 in the control condition).
2.4. Participants
One-hundred-and-forty-two female adolescents with elevated depression or anxiety symptoms
participated in this effectiveness trial. The adolescents were aged 11–14 years (M = 12.87, SD = 0.69),
and were in the first or second year of secondary education. Educational levels were: vocational
training (18.3%), vocational training/high school training (17.6%), high school training (15.5%), high
school training/pre-university training (30.3%), and pre-university training (18.3%). Most adolescents
had the Dutch nationality (97.2%), and the remaining adolescents (2.8%) had a different European and
non-European origin. Other baseline characteristics of the participants are shown in Table 1.
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Table 1. Baseline characteristics.
Variable
Total Sample
(N = 142)
Intervention
Condition
(N = 69)
Control
Condition
(N = 73) t
p
M SD M SD M SD
Adolescents
Age 12.87 0.69 12.84 0.73 12.90 0.66 −0.51 0.61
Nationality
Dutch 97.2% 97.1% 97.3%
Other 2.8% 2.9% 2.7%
Educational level
Vocational training 18.3% 20.3% 16.5%
Vocational/high school training 17.6% 17.4% 17.8%
High school training 15.5% 17.4% 13.7%
High school/pre-university training 30.3% 30.4% 30.1%
Pre-university training 18.3% 14.5% 21.9%
Symptom level
Depression symptoms 16.08 5.46 15.93 4.91 16.23 5.97 −0.33 0.74
Anxiety symptoms 45.76 12.24 47.78 12.14 43.85 12.12 1.93 0.06
Mothers
Age 43.89 4.41 44.03 4.19 43.76 4.63 0.32 0.75
Perceived maternal psychopathology 1.89 1.39 1.97 1.40 1.82 1.38 0.64 0.52
Maternal psychopathology 0.33 0.30 0.33 0.30 0.32 0.30 0.16 0.89
Fathers
Age 47.10 4.58 47.40 4.74 46.80 4.44 0.63 0.53
Perceived paternal psychopathology 1.11 1.21 0.99 1.01 1.22 1.37 −1.17 0.24
Paternal psychopathology 0.25 0.25 0.26 0.24 0.24 0.26 0.32 0.75
2.5. Randomization
Directly after screening, participants were randomly allocated to the conditions, stratified on
school, grade and educational level (allocation ratio (1:1)). The randomization was done by an
independent researcher using a computer-generated randomization procedure.
2.6. Intervention
The prevention program ‘Een Sprong Vooruit’ (A Leap Forward) was developed for adolescents
with parents with mental health problems and focuses on depression and anxiety prevention.
The program consists of six sessions, each 90 min and it mainly uses techniques based on cognitive
behavioral therapy, behavioral activation, and exposure, of which we know are effective in treating
depressive and anxiety disorders. The length of the program is a balance between a short program
with only few sessions to keep drop-out as low as possible and a long program with more sessions
to maximize usage of elements that are known to affect the symptoms. Adolescents will learn
about emotions and how to recognize them; relationships between activating events, beliefs and
consequences; strategies to replace pessimistic beliefs with optimistic beliefs; influence emotions
with behavior; divide fearful activities into small steps and experience the decrease in anxiety;
and how to get support from the social environment. The program ‘Een Sprong Vooruit’ uses
components of the Dutch depression prevention program ‘Op Volle Kracht’ [41–43], which is an
adapted version of the Penn Resiliency Program [44], components of the Dutch anxiety treatment
protocol ‘Denken + Doen = Durven’ [45], and is inspired by the Friends program [46]. A detailed
description of the program can be found in the study protocol [38].
Group size of the intervention groups varied between 6 and 12 adolescents per group (group
size M = 8.63, SD = 1.85), and the participants attended an average of 5.29 (1.34) sessions (median
6; range 0–6). Therapists were at least psychologists at master level. Further, treatment integrity
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was measured through a self-report questionnaire assessing which parts of the total program were
actually delivered, i.e., how many instructions and exercises the program were actually given to and
done by the participants. We calculated that therapists delivered an average of 95% of the program
(range 91–98%).
2.7. Measures
The Children’s Depression Inventory 2 (CDI-2) was used to measure depression symptoms [39].
This questionnaire contained 28 items, each consisting of three statements graded in severity from 0 to
2. Sample statements included “Sometimes I feel sad”, “Most of the times I feel sad”, and “I always
feel sad”. Sum scores were computed by adding together scores of all 28 items. Cronbach’s alpha was
0.71 at screening, 0.81 on T0, 0.83 at T1, 0.90 at T2, 0.89 at T3, 0.91 at T4, and 0.92 at T5. One of the
items of this questionnaire was used to assess suicidal ideation (Kovacs, 2012). The item has score
of 0 (“no suicidal ideation”), 1 (“thoughts of wanting to kill oneself, with no intent to do so”), and 2
(“a desire to kill oneself, if given the chance”). Participants with a score of 2 were directly referred to a
therapist within an institute of mental health care.
The Spence Children’s Anxiety Scale (SCAS) was used to measure anxiety symptoms [40].
The 44 items of this self-report questionnaire are rated on a 4-point scale ranging from “never” to
“always”. Sample statements were “I worry about things” and “I am scared of the dark”. Sum scores
were computed by summing up scores of all items, excluding the filler 11, 17, 26, 31, 38, and 43 (e.g.,
“I am popular amongst other kids of my own age”). Cronbach’s alpha was 0.81 at screening, 0.87 at T0,
0.91 at T1, 0.90 at T2, 0.92 at T3, 0.92 at T4, and 0.94 at T5.
The self-developed measure perceived parental psychopathology was used during the screening
of the female adolescents in order to assess whether parents had a history of or showed mental health
problems at that time [47]. Students responded to seven statements about parental psychopathology
for both mother and father, for example: “My parent received treatment from a psychologist or
psychiatrist”, “My parent had a decreased interest or pleasure in most or all activities”, with wording
of parent was replaced by either mother or father. Answers were rated as not present (0) or present (1).
We counted presence of one item as presence of perceived parental psychopathology. This measure
will be referred to as perceived parental psychopathology.
The Brief Symptoms Inventory (BSI) was used to measure parental psychopathology [48].
The self-report questionnaire is a short version of the Symptom Checklist-90 (SCL-90) [49] and measures
general symptoms of psychopathology. The 53 items were rated on a 5-point scale from “not at all” to
“extremely”. Sample statements were “Feeling no interest in things” and “Feeling tense or keyed up”.
Both mothers and fathers rated the questionnaire, resulting in scores on maternal and paternal
psychopathology. Mean scores were computed by averaging all items. Parental psychopathology
was measured at T0. Cronbach’s alpha was 0.94 for maternal psychopathology and 0.93 for paternal
psychopathology. This measure will be referred to as parental psychopathology.
2.8. Statistical Analyses
We conducted independent t-tests to analyze differences in the primary outcome measure
depression symptoms at all time-points. Further, we did the same for the secondary outcome measure
anxiety symptoms.
We applied latent growth curve modeling (LGCM) to examine the changes in the primary outcome
measure depression symptoms and the secondary outcome measure anxiety symptoms over time,
using Mplus version 6.11 [50]. To estimate the parameters in the models, we applied the maximum
likelihood estimator (ML). Using the full information maximum likelihood estimator has shown to
be the preferred method for handling missing data [51]. Model fit was assessed by χ2, Comparative
Fit Index (CFI: preferably 0.95 or higher), and Root Mean Square Error of Approximation (RMSEA:
preferably 0.05 or lower, and satisfactory between 0.05 and 0.08) [52].
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To examine the changes in depression and anxiety symptoms, we first tested models, separately
for depression and anxiety symptoms, without predictors. In these models, the mean of the intercept
provides information about the average level of depression or anxiety symptoms and the mean of
the slope represents the average change in depression or anxiety symptoms across the time-points.
Second, we added condition (i.e., whether the adolescents participated in the intervention or control
condition) to the models and tested separately for depression and anxiety symptoms whether the
growth functions for the intervention and the control condition were different.
3. Results
3.1. Descriptive Statistics
Means, standard deviations, and t-values for differences on depression symptoms between the
intervention and control condition were calculated (Table 2). As can be seen in Table 2, the level
of depression symptoms was not significantly different at baseline between participants in the
intervention condition compared to participants in the control condition. This is also the case for the
levels of depression symptoms during the intervention, after the intervention, and during follow-up.
The within-group effect sizes for change in total depression symptoms from baseline to 12-month
follow-up showed a small effects size (Cohen’s d = 0.35) in the intervention condition and no effect
(Cohen’s d = 0.18) in the control condition. Between-group difference in depression symptoms at
12-month follow-up showed no effect (Cohen’s d = 0.16). Measured at screening, depression symptoms
in adolescents were not correlated to perceived parental psychopathology in mothers (r = −0.05,
p = 0.58) and fathers (r = 0.04, p = 0.67). At baseline, depression symptoms were neither correlated
to parental psychopathology in neither mothers (r = −0.03, p = 0.75) nor fathers (r = 0.13, p = 0.20).
Perceived maternal psychopathology at screening showed to be significantly associated to maternal
psychopathology at baseline (r = 0.22, p = 0.01) and perceived paternal psychopathology at screening
was significantly associated to paternal psychopathology at baseline (r = 0.39, p < 0.001).
Further, means, standard deviations, and t-values for anxiety symptoms were calculated
between the intervention and control condition (Table 3). The level of anxiety symptoms was not
significantly different between participants in the intervention condition and control condition at
baseline, and neither during the intervention, after the intervention, and during the follow-up. The
within-group change in anxiety symptoms from baseline to 12-month follow-up showed a medium
effect size (Cohen’s d = 0.58) in the intervention condition and a medium effect size (Cohen’s d =
0.52) in the control condition, implying that both groups decreased substantially in symptom level.
Between-group difference in anxiety symptoms at 12-month showed no effect (Cohen’s d = 0.05).
Measured at screening, anxiety symptoms in adolescents were not correlated to perceived parental
psychopathology in mothers (r = 0.08, p = 0.37) and showed a small positive correlation to perceived
parental psychopathology in fathers (r = 0.17, p = 0.048). At baseline, anxiety symptoms were not
significantly correlated to parental psychopathology in neither mothers (r = −0.04, p = 0.69) nor fathers
(r = 0.04, p = 0.65).
Table 2. Means, standard deviations, and t-values for differences on depression symptoms between
the intervention and control condition.
Variable
Total Sample
(N = 142)
Intervention Condition
(N = 69)
Control Condition
(N = 73) t p
M SD M SD M SD
Depression symptoms screening 16.08 5.46 15.93 4.91 16.23 5.97 −0.33 0.74
Depression symptoms T0 14.44 6.50 14.32 5.89 14.54 7.04 −0.20 0.85
Depression symptoms T1 14.49 6.92 14.60 6.53 14.39 7.29 −0.17 0.87
Depression symptoms T2 14.07 8.40 13.80 6.92 14.29 9.48 −0.35 0.73
Depression symptoms T3 13.66 8.06 13.36 7.65 13.91 8.45 −0.39 0.70
Depression symptoms T4 13.04 8.96 11.98 7.84 13.98 9.82 −1.25 0.21
Depression symptoms T5 12.38 9.12 11.62 9.03 13.06 9.21 −0.90 0.37
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Table 3. Means, standard deviations, and t-values for differences on anxiety symptoms between the
intervention and control condition.
Variable
Total Sample
(N = 142)
Intervention Condition
(N = 69)
Control Condition
(N = 73) t p
M SD M SD M SD
Anxiety symptoms screening 45.76 12.24 47.78 12.14 43.85 12.12 1.93 0.06
Anxiety symptoms T0 37.77 13.58 38.97 13.51 36.69 13.62 0.98 0.33
Anxiety symptoms T1 37.29 15.78 37.52 16.52 37.10 15.23 0.15 0.88
Anxiety symptoms T2 35.69 15.11 36.57 15.37 34.99 14.98 0.59 0.55
Anxiety symptoms T3 33.19 16.03 33.92 16.41 32.57 15.79 0.48 0.64
Anxiety symptoms T4 32.81 16.18 32.72 16.19 32.89 16.23 −0.06 0.95
Anxiety symptoms T5 29.39 16.81 29.83 17.71 29.00 16.10 0.28 0.78
The retention rates were high with 137 (96.5%) adolescents completing the baseline assessment
(T0), 133 (93.7%) completing the intervention phase 1 assessment (T1), 131 (92.3%) completing the
intervention phase 2 assessment (T2), 131 (92.3%) completing the post-intervention assessment (T3),
125 (88.0%) completing the 6-month follow-up assessment (T4), and 130 (91.5%) completing the
12-month follow-up assessment (T5). Figure 1 presents the flow diagram of participants.
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3.2. Model Findings
First, the linear growth model for depression symptoms was tested. All six measures of depression
symptoms from baseline to 12-month follow-up were used to estimate a growth curve. The model
showed an acceptable fit (χ2 (15, N = 138) = 36.16, CFI = 0.97, and RMSEA = 0.10). Adding a quadratic
slope did not improve the model fit, and therefore we decided to use the linear model. It is known that
for small samples cut-off points for RMSEA are too restrictive [53] and acceptable models might be
over rejected [54]. Unfortunately, Mplus does not provide individual fit indices. Therefore, the model
was accepted. Next, we added condition as grouping variable to the model (χ2 (32, N = 138) = 66.25,
CFI = 0.95, and RMSEA = 0.13). The intercept (B = 14.26, p < 0.001) and slope (B =−0.21, p < 0.001) of the
intervention condition were both significant, showing that the depression symptoms were significantly
different from zero at baseline and decreased significantly over time. The intercept (B = 14.41, p < 0.001)
of the control condition was significant, but the slope (B = −0.11, p = 0.09) showed not to be significant,
indicating that the depression symptoms were significantly different from zero at baseline and did not
decrease over time. Finally, a Wald χ2 test (χ2 (1, N = 138) = 0.02, p = 0.89) showed that the intercepts of
depression symptoms were not significantly different between the intervention and control condition.
A Wald χ2 test for the slopes (χ2 (1, N = 138) = 1.46, p = 0.23) showed that the slopes of depression
symptoms in the intervention condition and the control condition were not significantly different.
Second, the model for anxiety symptoms was tested. Again, all six measures of anxiety symptoms
from baseline to 12-month follow-up were used in the estimation of the growth curve. The model
showed an acceptable fit (χ2 (16, N = 138) = 68.17, CFI = 0.92, and RMSEA = 0.15). Here again,
a quadratic slope did not improve the model fit. As mentioned before, RMSEA is known to be too
restrictive in small samples, and, therefore, the model was accepted. In the next step, we added
condition as a grouping variable to the model (χ2 (10, N = 138) = 85.34, CFI = 0.92, and RMSEA = 0.16).
The intercept (B = 37.00, p < 0.001) and slope (B = −0.54, p < 0.001) in the intervention condition were
both significant, indicating that anxiety symptoms were significantly different from zero at baseline and
decreased significantly over time. The intercept (B = 35.95, p < 0.001) and slope (B = −0.53, p < 0.001)
in the control condition were also both significant, showing that the anxiety symptoms at baseline
were significantly different from zero and that they significantly decreased over time. Finally, a Wald
χ2 test (χ2 (1, N = 138) = 0.20, p = 0.66) for intercepts showed no significant difference between the
intercepts of anxiety symptoms in the intervention condition and control condition. A Wald χ2 test
(χ2 (1, N = 138) = 0.002, p = 0.96) showed that the slopes of anxiety symptoms were not significantly
different between the intervention and control condition.
4. Discussion
In the present study, a randomized controlled trial was conducted to examine whether a novel
depression and anxiety prevention program ‘Een Sprong Vooruit’ had an effect on depression as
primary outcome and anxiety symptoms as secondary outcome in adolescent girls with a high familial
risk. In contrast to our hypothesis, participants in the intervention condition did not show a more
favorable trajectory on continuous measures of depression and anxiety symptoms than adolescents
in the control condition. The symptoms of depression decreased in participants in the intervention
condition and symptoms of anxiety decreased in participants in both conditions, although we found
no differences between conditions. This means that results showed that the program did not seem to
be effective in reducing symptoms. Strikingly, anxiety symptoms decreased significantly in the control
condition, without offering any form of intervention.
Comparing the results of the current study to other studies on the effectiveness of indicated
prevention gives us some interesting insights. Unlike findings in other studies on depression and
anxiety in adolescents with elevated symptoms [43,55], and a meta-analysis on the effectiveness
of depression prevention in children with parents with a depressive disorder [56], we found no
greater decrease in depression and anxiety symptoms in the intervention condition than in the control
condition. Our program was based on evidence-based treatment techniques for depression [57,58] as
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well as for anxiety disorders [59], and, therefore, we expected to find effects on both depression and
anxiety symptoms. There are several possible reasons for the lack of effect of the intervention in the
present study.
First, it can be the case that the program lacks focus on one technique, as it covers several
techniques in a relatively short time (six sessions of 90 min). That is, in the program adolescents
were trained in psycho-education, cognitive restructuring, behavioral activation, exposure, and
strengthening their social network. It could be that six sessions provide too little opportunity to become
well trained and therefore these techniques and the program as such, failed to reduce symptom levels.
Research suggests that the ability to incorporate techniques and processes offered by the interventions
is depending on the number of sessions of the intervention, and that eight sessions of one hour
(i.e., 480 min) might be insufficient [60]. Our program consists of six sessions of 90 min and the
total duration (540 min) is longer than the advised minimum. However, the fact that the program
contains several techniques means that the amount of time per technique may not be sufficient to
influence the development of depression or anxiety symptoms. Especially in the larger groups (i.e.,
12 adolescents per group), there was little time to practice and to individually tailor the examples
during the intervention.
A second possible reason for a lack of intervention effects is the quality of the match between
the participants and the prevention program. The program was developed as an efficient and light
program for both depression and anxiety prevention. Therefore, the program contains elements for both
depression and anxiety, as we mentioned before. Adolescents were included for their risk on depression
and anxiety based on elevated depression and/or anxiety symptoms. However, only slightly more
than 40% of the adolescents suffered from both elevated depression and anxiety symptoms. This
means that almost 60% showed only depression or anxiety symptoms, and were during the program
confronted with exercises that did not match with their needs, and these adolescents might have
profited more from a program specifically focused on either of them. This allows participants to
practice more with skills aimed at their own problems and prevention might be more effective for
these adolescents.
A third reason for a lack of effect might be the significant decrease in symptoms in adolescents in
the control condition. There are a multiple explanations for this decrease. Firstly, it might be explained
by the number of assessments the adolescents received. Adolescents in the intervention condition
received two assessments during and three assessments after the intervention and adolescents in the
control condition received assessments with the same interval. This might have led to awareness and
contributed to the decrease of symptoms in the control condition. A similar decrease in symptoms
in the control condition are described in several other studies [61,62]. Also, the adolescents received
attention of the researchers through telephone and email and this may have had a therapeutic
effect [63]. Secondly, the awareness of being observed and evaluated is known for its decreasing
effect on symptoms and is called the Hawthorne effect [64,65]. When participants know they are being
studied, they change their behavior and in this study this may have resulted in a decrease in symptoms.
Strengths of this study were the long-term follow-up measurements and the high retention
rates. Further, the prevention program was strongly based on theories about treatment techniques
for depression and anxiety. In addition, the group sessions of the prevention program showed
high treatment integrity. Therefore, we are allowed to interpret our results about effectiveness with
confidence [66]. Future should consider using independent ratings of treatment fidelity, for example
rating video-recordings of the sessions by an independent therapist. However, some limitations should
be mentioned. This study intended to measure changes in depression and anxiety symptoms during
the intervention. We assessed depression and anxiety symptoms two times during the intervention,
namely following the second session and following the fourth session. Yet, reporting too frequently on
their own depression and anxiety symptoms might have led to awareness of their mental wellbeing
and that in turn might have led to a reducing effect on symptoms. This may have led to an unintended
and unforeseen effect in the control condition. Further, data were collected only through self-report
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questionnaires, often mentioned to be subjective in measuring symptoms. Future studies should
consider adding a more objective measure of depression and anxiety, for example using a clinical
interview. Another suggestion is to include other factors that could identify risk, such as emotional
support of parents or conflict within the family.
5. Conclusions
In conclusion, the present study showed no intervention effects of ‘Een Sprong Vooruit’ in reducing
depression or anxiety symptoms compared to the control condition. We argued that prevention
programs should have a clear focus on either depression or anxiety prevention, resulting in more time
to practice skills to target these problems. Further, we recommended to target adolescents with less
heterogeneity in their symptoms (i.e., either depression or anxiety), so that they could benefit from
the complete program. Taking these suggestions into account, prevention program might be more
effective in improving mental health of adolescents.
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